Arctic stenosis is a common heart valve disease affecting mainly patients of advanced age. It is a common health problem with serious consequences since the Arctic valve is the central heart valve. The Contemporary treatment of this disease is the Transcatheter percutaneous aortic valve replacement (TAVI or TAVR). The results of these methods have been proven scientifically various trials and either equivalent or Superior to those of open heart surgery.
The indication of TAVI he’s for patience of advanced age with aortic stenosis high risk for open surgery. However recent trials have shown that this method is equivalent to Superior surgery even in moderate or low risk populations.
The technology has evolved rapidly current generation of transcatheter valves are extremely efficient, low profile, rapid to deploy and are usually performed with very few complications, low-risk, excellent hemodynamic performance, and is now a routine procedure to most experienced centers.